Kite and Sangamo signed a deal worth potentially more than $3 billion to jointly develop cellular immunotherapies using zinc finger nuclease gene-editing technologies.

中文翻译：

---

Sangamo Kite，基因编辑细胞疗法合作伙伴

风筝和Sangamo签署了一项潜在价值超过30亿美元的协议，共同使用锌指核酸酶基因编辑技术开发细胞免疫疗法。